Overview Saroglitazar Magnesium 4 mg for NASH in People Living With HIV in the US Status: Not yet recruiting Trial end date: 2025-03-01 Target enrollment: Participant gender: Summary Saroglitazar Magnesium 4 mg for NASH in People Living with HIV in the US Phase: Phase 2 Details Lead Sponsor: Zydus Therapeutics Inc.